Get 20M+ Full-Text Papers For Less Than $1.50/day. Start a 14-Day Trial for You or Your Team.

Learn More →

The Flip Side of Performance Measures: Comment on “The Other Side of Quality Improvement in Diabetes for Seniors”

The Flip Side of Performance Measures: Comment on “The Other Side of Quality Improvement in... Almost all performance measures are based on recommendations to do something—screen for cancer; reduce blood pressure, lipoprotein levels, or glycohemoglobin values; and start treatment with medications that reduce risk among persons with conditions such as coronary disease or congestive heart failure. Used in appropriate patients in the correct circumstances, these interventions have been shown to be beneficial. However, there is also ample evidence that overtreatment is harmful in many patients, especially those who are older and have other illnesses. In this issue of the Archives, Pogach and Aron suggest a performance measure that would penalize physicians and health care systems for a glycohemoglobin concentration of less than 7% among persons with diabetics who are older than 65 years and at risk for hypoglycemia. This measure of overtreatment and other similar measures have great potential to limit the adverse effects of overtreatment and to improve health. http://www.deepdyve.com/assets/images/DeepDyve-Logo-lg.png Archives of Internal Medicine American Medical Association

The Flip Side of Performance Measures: Comment on “The Other Side of Quality Improvement in Diabetes for Seniors”

Grady, Deborah
Archives of Internal Medicine , Volume 172 (19) – Oct 22, 2012
Download PDF
1 page

The Flip Side of Performance Measures: Comment on “The Other Side of Quality Improvement in Diabetes for Seniors”

Abstract

Almost all performance measures are based on recommendations to do something—screen for cancer; reduce blood pressure, lipoprotein levels, or glycohemoglobin values; and start treatment with medications that reduce risk among persons with conditions such as coronary disease or congestive heart failure. Used in appropriate patients in the correct circumstances, these interventions have been shown to be beneficial. However, there is also ample evidence that overtreatment is harmful in...
Loading next page...
 
/lp/american-medical-association/the-flip-side-of-performance-measures-comment-on-the-other-side-of-L6sv0dbZUE

References (6)

Publisher
American Medical Association
Copyright
Copyright © 2012 American Medical Association. All Rights Reserved.
ISSN
0003-9926
eISSN
1538-3679
DOI
10.1001/archinternmed.2012.4560
Publisher site
See Article on Publisher Site

Abstract

Almost all performance measures are based on recommendations to do something—screen for cancer; reduce blood pressure, lipoprotein levels, or glycohemoglobin values; and start treatment with medications that reduce risk among persons with conditions such as coronary disease or congestive heart failure. Used in appropriate patients in the correct circumstances, these interventions have been shown to be beneficial. However, there is also ample evidence that overtreatment is harmful in many patients, especially those who are older and have other illnesses. In this issue of the Archives, Pogach and Aron suggest a performance measure that would penalize physicians and health care systems for a glycohemoglobin concentration of less than 7% among persons with diabetics who are older than 65 years and at risk for hypoglycemia. This measure of overtreatment and other similar measures have great potential to limit the adverse effects of overtreatment and to improve health.

Journal

Archives of Internal Medicine – American Medical Association

Published: Oct 22, 2012

Keywords: diabetes mellitus,older adult,quality improvement

There are no references for this article.